Read on
There are funding gaps that hamper the development of circular/biobased projects in the EU. Private investors for now are reticent to invest, mainly due to perceived risks. Measures should be taken to manage these risks in a proper fashion.
Editorial office / Brussel

In May 2017, the European Investment Bank (EIB) published a study, performed by Ernst&Young. The report, devised in close collaboration with the Bio-based Industries Consortium and its members, aims to collect information on the access-to-finance conditions for larger investment projects in the domain of biobased and the blue economy. Furthermore, the study also explores the need and potential for public risk-sharing instruments as well as policy actions (EU and on a member state level, ed.) that would be able to attract funding from the investment community. First of all, what is the current situation in terms of capital investment? As for the public sector, the EU is investing 3,8 billion euro into the bio-economy in the period 2014-2020. The EU also participates with roughly 1 billion euro in the Bio-Based Industries Consortium: an investment that is matched by at least 2,7 billion euro of private investments.